Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging

In the last decade, PET-only systems have been phased out and replaced with PET-CT systems. This merger of a functional and anatomical imaging modality turned out to be extremely useful in clinical practice. Currently, PET-CT is a major diagnostic tool in oncology. At the dawn of the merger of MRI and PET, another breakthrough in clinical imaging is expected. The combination of these imaging modalities is challenging, but has particular features such as imaging biological processes at the same time in specific body locations.

• Publication year

  2010

• Venue

  European Radiology

• Publication date

  2010-12-21

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1007/s00330-010-2033-yPMID 21174096PMCID 3032196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT

  2011cited by this paper
• Hybrid PET/MRI of Intracranial Masses: Initial Experiences and Comparison to PET/CT

  2010cited by this paper
• PET/CT in primary musculoskeletal tumours: a step forward

  2010cited by this paper
• Impact of PET/CT on planning of radiotherapy in head and neck cancer.

  2010cited by this paper
• Utility of Preoperative 18F-FDG PET/CT and Brain MRI in Melanoma Patients with Palpable Lymph Node Metastases

  2010cited by this paper
• Comprehensive imaging of residual/recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT

  2010cited by this paper
• Role of PET/CT in ovarian cancer.

  2010cited by this paper
• PET/CT in head and neck cancer: an update

  2010cited by this paper
• A systematic review of the factors affecting accuracy of SUV measurements.

  2010cited by this paper
• Combined correction of recovery effect and motion blur for SUV quantification of solitary pulmonary nodules in FDG PET/CT

  2010cited by this paper
• PET/MRI: Paving the Way for the Next Generation of Clinical Multimodality Imaging Applications

  2010influential reference
• Cancer Statistics, 2009

  2010cited by this paper
• Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.

  2010cited by this paper
• PET versus PET/CT dual-modality imaging in evaluation of lung cancer.

  2010cited by this paper
• Evaluation of the effects of oral water and low-density barium sulphate suspension on bowel appearance on FDG-PET/CT

  2009cited by this paper
• Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer

  2009cited by this paper
• Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review

  2009cited by this paper
• CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck

  2009cited by this paper
• Observer Variation in Interpreting 18F-FDG PET/CT Findings for Lymphoma Staging

  2009cited by this paper
• Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Musculoskeletal pitfalls in 18F-FDG PET/CT: pictorial review.

  2009cited by this paper
• 18F-FDG PET/CT of transitional cell carcinoma.

  2009cited by this paper
• 18F-FDG PET/CT for Image-Guided and Intensity-Modulated Radiotherapy*

  2009cited by this paper
• The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

  2009cited by this paper
• Simultaneous PET-MRI: a new approach for functional and morphological imaging

  2008cited by this paper
• The prognostic value of PET and PET/CT in cervical cancer

  2008cited by this paper
• Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer

  2008cited by this paper
• The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients.

  2008cited by this paper
• MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration

  2008cited by this paper
• 1-11C-Acetate Kinetics of Prostate Cancer

  2008cited by this paper
• PET/MRI hybrid imaging: devices and initial results

  2008cited by this paper
• PET/CT: form and function.

  2007cited by this paper
• PET and PET/CT in management of the lymphomas.

  2007cited by this paper
• Detection of recurrent rectal cancer with CT, MRI and PET/CT

  2007cited by this paper
• Whole-body PET/CT-colonography: a possible new concept for colorectal cancer staging

  2007cited by this paper
• High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.

  2007cited by this paper
• FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.

  2007cited by this paper
• Dual-modality FDG-PET/CT in follow-up of patients with recurrent iodine-negative differentiated thyroid cancer

  2007cited by this paper
• Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.

  2007cited by this paper
• The contribution of PET/CT to improved patient management.

  2006cited by this paper
• PET/CT and radiotherapy.

  2006cited by this paper
• The role of PET/CT scanning in radiotherapy planning.

  2006cited by this paper
• Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI.

  2006cited by this paper
• False-Positive FDG PET Uptake−the Role of PET/CT

  2006cited by this paper
• Integrated PET/CT: current applications and future directions.

  2006cited by this paper
• The role of FDG‐PET/CT in suspected recurrence of breast cancer

  2006cited by this paper
• Whole-body MRI and PET-CT in the management of cancer patients

  2006cited by this paper
• Oncologic PET/CT: current status and controversies

  2005cited by this paper
• Performance of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography and Integrated PET/CT in Restaged Breast Cancer Patients

  2005cited by this paper
• Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?

  2005cited by this paper
• Clinical evaluation of a breathing protocol for PET/CT

  2004cited by this paper
• Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer

  2004cited by this paper
• Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer.

  2004cited by this paper
• PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies.

  2004cited by this paper
• Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT.

  2004cited by this paper
• Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

  2003cited by this paper
• Whole-body imaging with MRI or PET/CT: the future for single-modality imaging in oncology?

  2003cited by this paper
• PET/CT of the abdomen: optimizing the patient breathing pattern

  2003cited by this paper
• X-ray-based attenuation correction for positron emission tomography/computed tomography scanners.

  2003cited by this paper
• PET/CT in Colorectal Cancer.

  2003cited by this paper
• Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner

  2003cited by this paper
• Follow-up of women with breast cancer: comparison between MRI and FDG PET

  2003cited by this paper
• A tabulated summary of the FDG PET literature.

  2002cited by this paper
• Combining anatomy and function: the path to true image fusion

  2001influential reference
• A tabulated summary of the FDG PET literature.

  2001cited by this paper
• Inaugural Article: Positron emission tomography provides molecular imaging of biological processes

  2000cited by this paper
• Positron emission tomography as a diagnostic tool in oncology

  1998cited by this paper
• Whole-body positron emission tomography: Part I. Methods and performance characteristics.

  1992cited by this paper
• Cancer statistics

  1989cited by this paper
• Time-of-flight positron emission tomography: status relative to conventional PET.

  1983cited by this paper
• THE LOW‐TEMPERATURE SCINTILLATION PROPERTIES OF BISMUTH GERMANATE AND ITS APPLICATION TO HIGH‐ENERGY GAMMA RADIATION IMAGING DEVICES

  1980cited by this paper
• Potential advantages of a cesium fluoride scintillator for a time-of-flight positron camera.

  1980cited by this paper

• Open-source phantom with dedicated in-house software for image quality assurance in hybrid PET systems

  2025cites this paper
• Quantitative and qualitative evaluation of sequential PET/MRI using a newly developed mobile PET system for brain imaging

  2021cites this paper
• Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives.

  2020cites this paper
• Laboratory diagnosis of hematological and oncological diseases 2 . 1 Morphological methods

  2019cites this paper
• Very Early Response Evaluation by PET/MR in Patients with Lung Cancer—Timing and Feasibility

  2019cites this paper
• Qualitative and quantitative reproducibility of [18]fluoromethycholine PET/computed tomography in prostate cancer.

  2019cites this paper
• Proton Range Probe as a Tool for Image Guided Proton Therapy

  2017cites this paper
• Low-dose ion-based transmission radiography and tomography for optimization of carbon ion-beam therapy

  2017cites this paper
• Diagnostic Performance of Whole-Body PET/MRI for Detecting Malignancies in Cancer Patients: A Meta-Analysis

  2016cites this paper
• A new assessment model for tumor heterogeneity analysis with [18]F-FDG PET images

  2016cites this paper
• PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.

  2016cites this paper
• Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer

  2016cites this paper
• Correlative Imaging in a Patient with Cystic Thymoma: CT, MR and PET/CT Comparison

  2015cites this paper
• Localization and tracking of robotic endoscopic capsules using multiple positron emission markers

  2015cites this paper
• A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems

  2015cites this paper
• Performance comparison of Ingenuity TF PET/MRI and Gemini TF PET/CTscanners

  2014cites this paper
• Competitive advantage of PET/MRI.

  2014cites this paper
• Concept and simulation study of a novel localization method for robotic endoscopic capsules using multiple positron emission markers.

  2014cites this paper
• Direct evaluation of MR-derived attenuation correction maps for PET/MR of the mouse myocardium

  2014cites this paper
• Imaging requirements for personalized medicine: the oncologists point of view.

  2014cites this paper
• Evaluation of Neuroendocrine Liver Metastases: A Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography

  2014cites this paper
• Hybrid Imaging: PET-CT and PET-MRI

  2014cites this paper
• Identifying response to therapy in longitudinal PET imaging studies

  2014cites this paper
• Formation of multifunctional Fe3O4/Au composite nanoparticles for dual-mode MR/CT imaging applications

  2014cites this paper
• Simultaneous EEG-fMRI acquisition at low, high and ultra-high magnetic fields up to 9.4 T: Perspectives and challenges

  2014cites this paper
• Integrated PET/MR

  2014cites this paper
• Technical Principles and Protocols of PET/MR Imaging

  2013cites this paper
• Future of medicine: models in predictive diagnostics and personalized medicine.

  2013cites this paper
• Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer’s perspective

  2013cites this paper
• A New Heterogeneity Assessment Model for Tumors in 18F-FDG PET-CT Images

  2013cites this paper
• Multimodale Bildgebung in der pädiatrischen Onkologie

  2013influential citation
• Integrated Whole-Body PET/MR Hybrid Imaging: Clinical Experience

  2013cites this paper
• PET/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging.

  2012cites this paper
• Diagnostic value of combined 18F-FDG PET/MRI for staging and restaging in paediatric oncology

  2012cites this paper
• Multimodal imaging utilising integrated MR-PET for human brain tumour assessment

  2012cites this paper
• Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT

  2012cites this paper
• Cancer Diagnosis and Treatment: An Overview for the General Practitioner

  2012cites this paper
• Development of new fluorescent silica and multifunctional nanoparticles for bio-imaging and diagnostics

  2011cites this paper
• Molecular imaging using positron emission tomography in colorectal cancer.

  2011cites this paper
• Letter to the editor re: molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging

  2011cites this paper
• Role of PET/CT in ovarian cancer.

  2010cites this paper
• A systematic review of the factors affecting accuracy of SUV measurements.

  2010cites this paper
• Observer Variation in Interpreting 18F-FDG PET/CT Findings for Lymphoma Staging

  2009cites this paper